Aytu BioScience ( (AYTU) ) has issued an announcement.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Aytu BioPharma, Inc. announced a proposed settlement in a shareholder derivative lawsuit involving accusations of fiduciary breaches and unjust enrichment by company directors and Armistice Capital. The lawsuit alleges that these parties orchestrated transactions benefiting themselves at the expense of Aytu shareholders. A court hearing is scheduled for January 2025 to determine the fairness of the settlement, which aims to resolve claims and potentially improve corporate governance practices.
See more insights into AYTU stock on TipRanks’ Stock Analysis page.
